The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Open accessAbstract
Insulin-like growth factors (IGFs) are essential for growth and survival that suppress apoptosis and promote cell cycle progression, angiogenesis, and metastatic activities in various cancers. The IGFs actions are mediated through the IGF-1 receptor that is involved in cell transformation induced by tumour. These effects depend on the bioavailability of IGFs, which is regulated by IGF binding proteins (IGFBPs). We describe here the role of the IGF system in cancer, proposing new strategies targeting this system. We have attempted to expand the general viewpoint on IGF-1R, its inhibitors, potential limitations of IGF-1R, antibodies and tyrosine kinase inhibitors, and IGFBP actions. This review discusses the emerging view that blocking IGF via IGFBP is a better option than blocking IGF receptors. This can lead to the development of novel cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Investigative Ophthalmology and Visual Science
Frey, C. (2010) · Cited by 3,350
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Scott, A. M., Wolchok, J. D., & Old, L. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3236 · Cited by 2,160
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Nutritional Regulation of the Insulin-Like Growth Factors*
THISSEN, J.-P., KETELSLEGERS, J.-M., & UNDERWOOD, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,579
Nutritional regulation of the insulin-like growth factors
Thissen, J. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.1.80 · Cited by 1,578
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Insulin-like growth factor II receptor as a multifunctional binding protein
Morgan, D. O., Edman, J. C., Standring, D. N., Fried, V. A., Smith, M. C., Roth, R. A., & Rutter, W. J. (1987) · Nature · doi:10.1038/329301a0 · Cited by 853
Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs
Verma, R. P., & Hansch, C. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.011 · Cited by 783
Stewart, C. E., & Rotwein, P. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.4.1005 · Cited by 776
Insulin-like Growth Factor Binding Proteins
Rechler, M. M. (1993) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60444-6 · Cited by 755
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Lawrence, J. B., Oxvig, C., Overgaard, M. T., Sottrup-Jensen, L., Gleich, G. J., Hays, L. G., Yates, J. R., & Conover, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3149 · Cited by 706
The IGF‐1 receptor in cancer biology
Baserga, R., Peruzzi, F., & Reiss, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11487 · Cited by 642
Coleman, M. E., DeMayo, F., Yin, K. C., Lee, H. M., Geske, R., Montgomery, C., & Schwartz, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12109 · Cited by 642
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Garcı́a-Echeverrı́a, C., Pearson, M. A., Marti, A., Meyer, T., Mestan, J., Zimmermann, J., Gao, J., Brueggen, J., Capraro, H.-G., Cozens, R., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00051-0 · Cited by 542
IGF binding proteins in cancer: mechanistic and clinical insights
Baxter, R. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3720 · Cited by 525
Growth Hormone Stimulates Longitudinal Bone Growth Directly
Isaksson, O. G. P., Jansson, J.-O., & Gause, I. A. M. (1982) · Science · doi:10.1126/science.7079756 · Cited by 525
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
De Mellow, J. S. M., & Baxter, R. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80824-6 · Cited by 483
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Chitnis, M. M., Yuen, J. S. P., Protheroe, A. S., Pollak, M., & Macaulay, V. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4879 · Cited by 445
Evidence that somatomedin is synthesized by multiple tissues in the fetus
D'Ercole, A. J., Applewhite, G. T., & Underwood, L. E. (1980) · Developmental Biology · doi:10.1016/0012-1606(80)90166-9 · Cited by 437
Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7
Oh, Y., Nagalla, S. R., Yamanaka, Y., Kim, H.-S., Wilson, E., & Rosenfeld, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30322 · Cited by 375
HAN, V. K. M., LUND, P. K., LEE, D. C., & D'ERCOLE, J. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-422 · Cited by 371
Werner, H., Karnieli, E., Rauscher, F. J., & LeRoith, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8318 · Cited by 370
Targeted therapies for breast cancer
Higgins, M. J., & Baselga, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57152 · Cited by 369
Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth
Girnita, A., Girnita, L., Prete, F. D., Bartolazzi, A., Larsson, O., & Axelson, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2522 · Cited by 363
Zhao, G., Monier-Faugere, M.-C., Langub, M. C., Geng, Z., Nakayama, T., Pike, J. W., Chernausek, S. D., Rosen, C. J., Donahue, L.-R., Malluche, H. H., et al. (2000) · Endocrinology · doi:10.1210/endo.141.7.7585 · Cited by 359
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., & Jirtle, R. L. (1995) · Nature Genetics · doi:10.1038/ng1295-447 · Cited by 355
From genes to drugs: targeted strategies for melanoma
Flaherty, K. T., Hodi, F. S., & Fisher, D. E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3218 · Cited by 354
Gershon, D. (2003) · Nature · doi:10.1038/nj6934-928a · Cited by 352
Fowlkes, J. L., Enghild, J. J., Suzuki, K., & Nagase, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47310-3 · Cited by 347
Genistein Chemoprevention: Timing and Mechanisms of Action in Murine Mammary and Prostate
Lamartiniere, C. A., Cotroneo, M. S., Fritz, W. A., Wang, J., Mentor-Marcel, R., & Elgavish, A. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.3.552s · Cited by 332
Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K., Agarwal, M. L., & Mukhtar, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206708 · Cited by 325
Chinni, S. R., Li, Y., Upadhyay, S., Koppolu, P. K., & Sarkar, F. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204365 · Cited by 315
Expression and characterization of a functional human insulin-like growth factor I receptor.
Steele-Perkins, G., Turner, J., Edman, J. C., Hari, J., Pierce, S. B., Stover, C., Rutter, W. J., & Roth, R. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37983-3 · Cited by 314
Insulin-Like Growth Factor I (IGF-I)-Binding Protein Complex Is a Better Mitogen than Free IGF-I*
BLUM, W. F., JENNE, E. W., REPPIN, F., KIETZMANN, K., RANKE, M. B., & BIERICH, J. R. (1989) · Endocrinology · doi:10.1210/endo-125-2-766 · Cited by 311
IGF1R signalling and its inhibition
Riedemann, J., & Macaulay, V. M. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01280 · Cited by 301
Jones, J. I., D'Ercole, A. J., Camacho-Hubner, C., & Clemmons, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7481 · Cited by 299
Reiss, K., Cheng, W., Ferber, A., Kajstura, J., Li, P., Li, B., Olivetti, G., Homcy, C. J., Baserga, R., & Anversa, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8630 · Cited by 292
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Demonstration of Specific Plasma Protein Binding Sites For Somatomedin
HINTZ, R. L., & LIU, F. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-988 · Cited by 270
Overgaard, M. T., Boldt, H. B., Laursen, L. S., Sottrup-Jensen, L., Conover, C. A., & Oxvig, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102191200 · Cited by 267
Ye, P., Carson, J., & D'Ercole, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07344.1995 · Cited by 265
Binding of nonsuppressible insulinlike activity to human serum
Zapf, J., WALDVOGEL, M., & Froesch, E. R. (1975) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(75)90296-9 · Cited by 255
Igf1 promotes longitudinal bone growth by insulin‐like actions augmenting chondrocyte hypertrophy
Wang, J., Zhou, J., & Bondy, C. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1985 · Cited by 253
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Belfiore, A. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249173 · Cited by 252
Oshima, A., Nolan, C. M., Kyle, J. W., Grubb, J. H., & Sly, W. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69243-9 · Cited by 244
Conover, C. A. (1992) · Endocrinology · doi:10.1210/en.130.6.3191 · Cited by 230
Butt, A. J., Firth, S. M., King, M. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908888199 · Cited by 214
Swami, S., Raghavachari, N., Muller, U. R., Bao, Y. P., & Feldman, D. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024487118457 · Cited by 205
Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer
Majumdar, A. P. N., Banerjee, S., Nautiyal, J., Patel, B. B., Patel, V., Du, J., Yu, Y., Elliott, A. A., Levi, E., & Sarkar, F. H. (2009) · Nutrition and Cancer · doi:10.1080/01635580902752262 · Cited by 201
Wu, Y., Cui, K. Y., Miyoshi, K., Hennighausen, L. G., Green, J. E., Setser, J., LeRoith, D., & Yakar, S. (2003) · PubMed · Cited by 201
Wang, J., Niu, W., Nikiforov, Y., Naito, S., Chernausek, S., Witte, D., LeRoith, D., Strauch, A., & Fagin, J. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119663 · Cited by 199
Targeting cancer stem cells by curcumin and clinical applications
Li, Y., & Zhang, T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.012 · Cited by 189
Insulin-Like Growth Factor Binding Proteins: A Structural Perspective
Forbes, B. E., McCarthy, P., & Norton, R. S. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00038 · Cited by 189
Veeken, J., Oliveira, S., Schiffelers, R., Storm, G., Henegouwen, P. M. P., & Roovers, R. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789271495 · Cited by 189
Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?
Hoeflich, A., Reisinger, R., Lahm, H., Kiess, W., Blum, W. F., Kolb, H. J., Weber, M. M., & Wolf, E. (2001) · PubMed · Cited by 187
Perspectives in mammalian IGFBP-3 biology: local vs. systemic action
Yamada, P. M., & Lee, K.-W. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00598.2008 · Cited by 177
Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
Yee, D. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs258 · Cited by 177
Natural Products: Promising Resources for Cancer Drug Discovery
Mondal, S., Bandyopadhyay, S., K. Ghosh, M., Mukhopadhyay, S., Roy, S., & Mandal, C. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012798764697 · Cited by 177
IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors
Evdokimova, V., Tognon, C. E., Benatar, T., Yang, W., Krutikov, K., Pollak, M., Sorensen, P. H. B., & Seth, A. (2012) · Science Signaling · doi:10.1126/scisignal.2003184 · Cited by 176
Type-2 IGF Receptor: A Multi-Ligand Binding Protein
Braulke, T. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978725 · Cited by 166
Rodon, J., DeSantos, V., Ferry, R. J., & Kurzrock, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0265 · Cited by 162
Monget, P., Mazerbourg, S., Delpuech, T., Maurel, M.-C., Manière, S., Zapf, J., Lalmanach, G., Oxvig, C., & Overgaard, M. T. (2002) · Biology of Reproduction · doi:10.1095/biolreprod.102.007609 · Cited by 160
Ye, P., Xing, Y., Dai, Z., & D'Ercole, A. J. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00492-0 · Cited by 159
Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
Takeuchi, K., & Ito, F. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1774 · Cited by 159
Khan, N., Hadi, N., Afaq, F., Syed, D. N., Kweon, M.-H., & Mukhtar, H. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl145 · Cited by 158
Vasilcanu, D., Girnita, A., Girnita, L., Vasilcanu, R., Axelson, M., & Larsson, O. (2004) · Oncogene · doi:10.1038/sj.onc.1208065 · Cited by 152
Chen, J., Shao, Z., Sheikh, M. S., Hussain, A., LeRoith, D., Roberts, C. T., & Fontana, J. A. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041580110 · Cited by 151
Miyake, H., Pollak, M., & Gleave, M. E. (2000) · PubMed · Cited by 144
Surmacz, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206772 · Cited by 143
di Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., & Baserga, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1084 · Cited by 141
Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases
Fowlkes, J. L., Thrailkill, K. M., Serra, D. M., Suzuki, K., & Nagase, H. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00017-8 · Cited by 138
Chrysis, D., Calikoglu, A. S., Ye, P., & D’Ercole, A. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01481.2001 · Cited by 138
Myal, Y., Shiu, R. P. C., Bhaumick, B., & Bala, M. (1984) · PubMed · Cited by 138
Insulin-like growth factor-I and prostate cancer: a meta-analysis
Shi, R., Berkel, H. J., & Yu, H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1961 · Cited by 136
Butt, A. J., Dickson, K. A., McDougall, F. K., & Baxter, R. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301965200 · Cited by 135
Heazlewood, S. Y., Neaves, R. J., Williams, B., Haylock, D. N., Adams, T. E., & Nilsson, S. K. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.05.007 · Cited by 132
Defining the pathway to insulin-like growth factor system targeting in cancer
Rosenzweig, S. A., & Atreya, H. S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.013 · Cited by 130
Self-citationOates, A., Schumaker, L. M., Jenkins, S., Pearce, A. A., DaCosta, S. A., Arun, B. K., & Ellis, M. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005959218524 · Cited by 129
Leu, J. I.-J., Crissey, M. A. S., & Taub, R. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16712 · Cited by 129
Rupp, C., Scherzer, M., Rudisch, A., Unger, C., Haslinger, C., Schweifer, N., Artaker, M., Nivarthi, H., Moriggl, R., Hengstschläger, M., et al. (2014) · Oncogene · doi:10.1038/onc.2014.18 · Cited by 128
Frattali, A. L., & Pessin, J. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53187-2 · Cited by 127
Wang, G. K., Hu, L., Fuller, G. N., & Zhang, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513686200 · Cited by 126
Russo, V. C., Schüett, B. S., Andaloro, E., Ymer, S. I., Hoeflich, A., Ranke, M. B., Bach, L. A., & Werther, G. A. (2005) · Endocrinology · doi:10.1210/en.2005-0467 · Cited by 125
Mazerbourg, S., Overgaard, M. T., Oxvig, C., et al. (2001) · Endocrinology · doi:10.1210/endo.142.12.8517 · Cited by 125
Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
Gao, J., Chesebrough, J. W., Cartlidge, S. A., Ricketts, S., Incognito, L., Veldman-Jones, M. H., Blakey, D. C., Tabrizi, M. A., Jallal, B., Trail, P. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2274 · Cited by 124
Structure and function of the insulin-like growth factor I receptor
Sepp‐Lorenzino, L. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005955017615 · Cited by 122
Targeting the insulin-like growth factor-1 receptor in human cancer
Arcaro, A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00030 · Cited by 122
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
Yuen, J. S. P., & Macaulay, V. M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.589 · Cited by 120
Sultana, N. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2010.546793 · Cited by 118
Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulators of cell growth
Rajah, R., Katz, L. E. L., Nunn, S. E., et al. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00012-7 · Cited by 117
Ogawa, O., Becroft, D. M. O., Morison, I. M., Eccles, M. R., Skeen, J., Mauger, D. C., & Reeve, A. E. (1993) · Nature Genetics · doi:10.1038/ng1293-408 · Cited by 116
Gene Expression Profiles of Genistein-Treated PC3 Prostate Cancer Cells
Li, Y., & Sarkar, F. H. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3623 · Cited by 112
The First Sequence: Fred Sanger and Insulin
Stretton, A. O. W. (2002) · Genetics · doi:10.1093/genetics/162.2.527 · Cited by 111
MacDonald, R. G., Tepper, M. A., Clairmont, K. B., Perregaux, S. B., & Czech, M. P. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94060-3 · Cited by 110
Wang, J., Niu, W., Witte, D. P., Chernausek, S. D., Nikiforov, Y. E., Clemens, T. L., Sharifi, B. G., Strauch, A. R., & Fagin, J. A. (1998) · Endocrinology · doi:10.1210/endo.139.5.5986 · Cited by 108
Insulin-like growth factor binding proteins: gene structure and expression.
Mm, R., & Al, B. (1992) · PubMed · Cited by 108
Hernández‐Sánchez, C., Werner, H., Roberts, C. T., Woo, E. J., Hum, D. W., Rosenthal, S. M., & LeRoith, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4663 · Cited by 107
Li, Y., Li, X., & Sarkar, F. H. (2003) · Journal of Nutrition · doi:10.1093/jn/133.4.1011 · Cited by 107
Réhault‐Godbert, S., Monget, P., Mazerbourg, S., Tremblay, R. R., GUTMAN, N., Gauthier, F., & Moreau, T. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02185.x · Cited by 106
The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
Pollak, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0998 · Cited by 105
Insulin-Like Growth Factor Binding Protein-6: The “Forgotten” Binding Protein?
Bach, L. A. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978723 · Cited by 104
Insulin, insulin-like growth factors and neoplasia
Pollak, M. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.004 · Cited by 104
IGFBP-6 five years on; not so ‘forgotten’?
Bach, L. A. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.04.001 · Cited by 104
Tea Polyphenols and Their Roles in Cancer Prevention and Chemotherapy
Chen, D., & Dou, Q. P. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9071196 · Cited by 103
Slomiany, M. G., & Rosenzweig, S. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0565 · Cited by 100
McCaig, C., Perks, C. M., & Holly, J. M. P. (2002) · Journal of Cell Science · doi:10.1242/jcs.00097 · Cited by 98
Miyakoshi, N., Qin, X., Kasukawa, Y., Richman, C., Srivastava, A. K., Baylink, D. J., & Mohan, S. (2001) · Endocrinology · doi:10.1210/endo.142.6.8192 · Cited by 98
Insulin-like growth factor-binding protein-6 and cancer
Bach, L. A., Fu, P., & Yang, Z. (2012) · Clinical Science · doi:10.1042/cs20120343 · Cited by 97
p53 and IGFBP-3: Apoptosis and Cancer Protection
Grimberg, A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3008 · Cited by 96
Parker, A., Gockerman, A., Busby, W. H., & Clemmons, D. R. (1995) · Endocrinology · doi:10.1210/endo.136.6.7538463 · Cited by 96
Zhao, G. (2000) · Endocrinology · doi:10.1210/en.141.7.2674 · Cited by 94
Imai, Y., Busby, W. H., Smith, C. E., Clarke, J. B., Garmong, A., Horvitz, G. D., Rees, C. A., & Clemmons, D. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119803 · Cited by 92
The Role of IGF-1R in Pediatric Malignancies
Kim, S. Y., Toretsky, J. A., Scher, D., & Helman, L. J. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0189 · Cited by 90
Biology of insulin-like growth factor binding protein-4 and its role in cancer (review)
Durai, R., Davies, M., Yang, W., Yang, S. Y., Seifalian, A. M., Goldspink, G., & Winslet, M. C. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.6.1317 · Cited by 89
Takaoka, M., Harada, H., Andl, C. D., Oyama, K., Naomoto, Y., Dempsey, K. L., Klein–Szanto, A. J., El‐Deiry, W. S., Grimberg, A., & Nakagawa, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0715 · Cited by 89
Adachi, Y., Lee, C., Coffee, K. A., Yamagata, N., Ohm, J. E., Park, K., Dikov, M. M., Nadaf, S., Arteaga, C. L., & Carbone, D. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.36023 · Cited by 88
Targeting the insulin growth factor receptor 1
Arnaldez, F. I., & Helman, L. J. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.01.004 · Cited by 88
Krassas, G. E., Pontikides, N., Kaltsas, T., Dumas, A., Frystyk, J., Chen, J. W., & Flyvbjerg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021349 · Cited by 87
D'Ercole, A. J., Dai, Z., Xing, Y., Boney, C. M., Wilkie, M. B., Lauder, J. M., Han, V. K. M., & Clemmons, D. R. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)90164-3 · Cited by 85
Song, S. W., Fuller, G. N., Khan, A. U., Kong, S., Shen, W., Taylor, E., Ramdas, L., Lang, F. F., & Zhang, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332186100 · Cited by 85
Matrix Metalloprotease-3 and -9 Proteolyze Insulin-Like Growth Factor-Binding Protein-11
Coppock, H. A., White, A. E., Aplin, J., & Westwood, M. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.023101 · Cited by 84
Significant expression of IGFBP2 in breast cancer compared with benign lesions
Busund, L. T., Richardsen, E. H., Busund, R., Ukkonen, T., Bjørnsen, T., Busch, C., & Stalsberg, H. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.020834 · Cited by 83
Insulin-like Growth Factor Binding Protein 7 Mediates Glioma Cell Growth and Migration
Jiang, W., Xiang, C., Cazacu, S., Brodie, C., & Mikkelsen, T. (2008) · Neoplasia · doi:10.1593/neo.08694 · Cited by 82
Zhu, B., Zhao, G., Witte, D. P., Hui, D. Y., & Fagin, J. A. (2001) · Endocrinology · doi:10.1210/endo.142.8.8331 · Cited by 81
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment
Bohula, E. A., Playford, M. P., & Macaulay, V. M. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200310000-00001 · Cited by 80
Sprenger, C. C. T., Vail, M. E., Evans, K., Simurdak, J., & Plymate, S. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205021 · Cited by 80
Vasilcanu, R., Vasilcanu, D., Rosengren, L., Natalishvili, N., Sehat, B., Yin, S., Girnita, A., Axelson, M., Girnita, L., & Larsson, O. (2007) · Oncogene · doi:10.1038/sj.onc.1210797 · Cited by 78
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function
Cobb, L. J., Salih, D. A. M., Gonzalez, I., Tripathi, G., Carter, E. J., Lovett, F. A., Holding, C., & Pell, J. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01028 · Cited by 76
Ni, W., Rajkumar, K., Nagy, J. I., & Murphy, L. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00676-8 · Cited by 74
Rosenthal, S. M., Brown, E. J., Brunetti, A., & Goldfine, I. D. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-678 · Cited by 72
Dentremont, K. D., Ye, P., D’Ercole, A. J., & OʼKusky, J. R. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00024-3 · Cited by 71
Value of Insulin-like Growth Factor System Markers in the Assessment of Growth Hormone Status
Clemmons, D. R. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.008 · Cited by 70
Neumann, G. M., & Bach, L. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14587 · Cited by 69
Menu, E., Jernberg‐Wiklund, H., Raeve, H. D., Leenheer, E. D., Coulton, L. A., Gallagher, O., Valckenborgh, E. V., Larsson, O., Axelson, M., Nilsson, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22845 · Cited by 69
Endoglin Regulates Cancer–Stromal Cell Interactions in Prostate Tumors
Romero, D., O'Neill, C., Terzic, A., Contois, L. W., Young, K. A., Conley, B. A., Bergan, R. C., Brooks, P. C., & Vary, C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2665 · Cited by 68
Li, X., Feng, Y., Liu, J., Feng, X., Zhou, K., & Tang, X. (2013) · Lifestyle Genomics · doi:10.1159/000354402 · Cited by 66
Insulin-Like Growth Factor I (IGF-I) Regulates IGF Binding Protein-5 Gene Expression in the Brain
Ye, P., & D’Ercole, J. A. (1998) · Endocrinology · doi:10.1210/en.139.1.65 · Cited by 65
Ryan, A. J., Napoletano, S., Fitzpatrick, P. A., Currid, C. A., O’Sullivan, N. C., & Harmey, J. H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605141 · Cited by 65
Toretsky, J. A., Steinberg, S. M., Thakar, M., Counts, D., Pironis, B., Carrie Parente, B. A., Eskenazi, A. E., Helman, L. J., & Wexler, L. H. (2001) · Cancer · Cited by 65
Zaina, S., & Squire, S. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28610 · Cited by 64
Promotion of Cancer Cell Migration
Fu, P., Thompson, J. A., & Bach, L. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703066200 · Cited by 63
Yee, D., Jackson, J. G., Kozelsky, T. W., & Figueroa, J. A. (1994) · PubMed · Cited by 62
Tanno, B., Cesi, V., Vitali, R., Sesti, F., Giuffrida, M. L., Mancini, C., Calabretta, B., & Raschellà, G. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401546 · Cited by 61
Miyamoto, S., Nakamura, M., Yano, K., Ishii, G., Hasebe, T., Endoh, Y., Sangai, T., Maeda, H., Shi‐chuang, Z., Chiba, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00448.x · Cited by 59
Armengol, G., Knuutila, S., Lluı́s, F., Capellá, G., Miró, R., & Caballín, M. R. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00118-1 · Cited by 58
Nickerson, T., Miyake, H., Gleave, M. E., & Pollak, M. (1999) · PubMed · Cited by 57
The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer
Almeida, A., Muleris, M., Dutrillaux, B., & Malfoy, B. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110110 · Cited by 56
Majeed, N., Blouin, M., Kaplan‐Lefko, P. J., Barry-Shaw, J., Greenberg, N. M., Gaudreau, P., Bismar, T. A., & Pollak, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208572 · Cited by 56
Valenzano, K. J., Remmler, J. L., & Lobel, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16441 · Cited by 55
Costello, M., Baxter, R. C., & Scott, C. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.611 · Cited by 55
Insulinlike Growth Factor-Binding Protein Proteolysis
Fowlkes, J. L. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00112-4 · Cited by 53
Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells
Sokolović, A., Sokolović, M., BOERS, W., Elferink, R. P. J. O., & Bosma, P. J. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-3 · Cited by 53
Zhang, M., Smith, E. P., Kuroda, H., Banach, W., Chernausek, S. D., & Fagin, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112082200 · Cited by 50
Mancini, M., Gariboldi, M. B., Taìana, E., Bonzi, M. C., Craparotta, I., Pagin, M., & Monti, E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.269 · Cited by 46
Rees, C., Clemmons, D. R., Horvitz, G. D., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.6266 · Cited by 43
Jung, M., Bu, S. Y., Tak, K.-H., Park, J.-E., & Kim, E. (2013) · Nutrition Research and Practice · doi:10.4162/nrp.2013.7.6.439 · Cited by 43
Xu, X. L., Lee, T. C., Offor, N., Cheng, C., Liu, A., Fang, Y., Jhanwar, S. C., Abramson, D. H., & Cobrinik, D. E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090512 · Cited by 40
IGFBP-4 Anti-Angiogenic and Anti-Tumorigenic Effects Are Associated with Anti-Cathepsin B Activity
Moreno, M., Ball, M., Rukhlova, M., Slinn, J., L’Abbé, D., Iqbal, U. H., Monette, R., Hagedorn, M., O'Connor‐McCourt, M. D., Durocher, Y., et al. (2013) · Neoplasia · doi:10.1593/neo.13212 · Cited by 38
Diehl, D., Hessel, E., Oesterle, D., Renner‐Müller, I., Elmlinger, M. W., Langhammer, M., Göttlicher, M., Wolf, E., Lahm, H., & Hoeflich, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.24193 · Cited by 37
Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth
Johnson, S., & Haun, R. S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3355 · Cited by 34
Neuhouser, M. L., Platz, E. A., Till, C., Tangen, C. M., Goodman, P. J., Kristal, A. R., Parnes, H. L., Tao, Y., Figg, W. D., Lucia, M. S., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0250 · Cited by 34
Zhang, W., Thornton, W. H., & MacDonald, R. S. (1998) · Journal of Nutrition · doi:10.1093/jn/128.2.158 · Cited by 32
Zhao, G., Sutliff, R. L., Weber, C. S., Wang, J., Lorenz, J. N., Paul, R. J., & Fagin, J. A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7941 · Cited by 31
Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance
Wolf, S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i2.156 · Cited by 30
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
Mosig, R., Lobl, M., Senturk, E., Shah, H., Cohen, S., Chudin, E., Fruscio, R., Marchini, S., D’Incalci, M., Sachidanandam, R., et al. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-3 · Cited by 30
Iwashita, M., Kudo, Y., & Takeda, Y. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.4.401 · Cited by 29
Okabe, E., Kajihara, J.-I., Usami, Y., & Hirano, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00275-6 · Cited by 27
Insulin-like growth factor binding protein-related protein 1 and cancer
Zhu, S., Xu, F., Zhang, J., Ruan, W., & Lai, M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.037 · Cited by 26
Kuang, Z., Yao, S., McNeil, K. A., Thompson, J. A., Bach, L. A., Forbes, B. E., Wallace, J. C., & Norton, R. S. (2007) · Biochemistry · doi:10.1021/bi701251d · Cited by 26
Soh, C.-L., McNeil, K. A., Owczarek, C. M., Hardy, M. P., Fabri, L., Pearse, M. J., Delaine, C. A., & Forbes, B. E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.232 · Cited by 25
Mohanraj, L., & Oh, Y. (2011) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489211795328512 · Cited by 25
Kim, W., Kim, M.-J., Moon, H., et al. (2011) · Endocrinology · doi:10.1210/en.2010-0693 · Cited by 21
Targeting EGFR and IGF 1R a promising combination therapy for metastatic cancer
Singh, I. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s369 · Cited by 20
Bartling (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000317 · Cited by 18
Berg, U., Bang, P., & Carlsson‐Skwirut, C. (2007) · Biological Chemistry · doi:10.1515/bc.2007.098 · Cited by 15
Dyck, M. K., Parlow, A. F., Sénéchal, J., Sirard, M., & Pothier, F. (2001) · Molecular Reproduction and Development · doi:10.1002/mrd.1020 · Cited by 13
New Aspect on Etiology and Therapy of Collagen Diseases and Inflammatory Bowel Diseases
Abo, T., Hidenobu, M. O. R. I., Yokoyama, H., & Miyazawa, S. (2002) · Biomedical Research · doi:10.2220/biomedres.23.55 · Cited by 4
Cited by
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016) · Journal of Cancer · doi:10.7150/jca.16884 · Cited by 335
MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
Moon, H., & Ro, S. W. (2021) · Cancers · doi:10.3390/cancers13123026 · Cited by 326
Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278
Hirz, T., Mei, S., Sarkar, H., Kfoury, Y., Wu, S., Verhoeven, B. M., Subtelny, A. O., Zlatev, D. V., Wszolek, M. W., Salari, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36325-2 · Cited by 277
Fuller, J. T., Hartland, M. C., Maloney, L. T., & Davison, K. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098285 · Cited by 199
Metadata
- Authors
- Brahmkhatri, V. P., Prasanna, C., & Atreya, H. S.
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-24
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W1974502272
- Cited by
- 279
- References
- 192
- FWCI
- 26.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.